Ma S W, Zhao D L, Yin Z Q, Mukherjee R, Singh B, Qin H Y, Stiller C R, Jevnikar A M
Transplantation Immunobiology Group, John P. Robarts Research Institute, University of Western Ontario, London, Canada.
Nat Med. 1997 Jul;3(7):793-6. doi: 10.1038/nm0797-793.
Oral administration of protein can induce antigen-specific immune hyporesponsiveness. However, the utility of oral tolerance to autoantigens in the treatment of autoimmune diseases may be limited when candidate autoantigens cannot be produced by conventional systems in quantities sufficient for clinical studies. Plants may be ideally suited for this purpose, as they can synthesize, glycosylate and assemble mammalian proteins to provide huge quantities of relatively low cost soluble proteins. Furthermore, edible transgenic plants could provide a simple and direct method of autoantigen delivery for oral tolerance. Therefore, the aim of this study was to determine whether a transgenic plant expression system was capable of synthesizing the diabetes-associated autoantigen, glutamic acid decarboxylase (GAD) in an immunogenic form and whether the oral administration of an autoantigen expressed by a plant could directly induce protective immune responses in a mouse model of diabetes. We show that a GAD-expressing transgenic plant, given as a dietary supplement, inhibits the development of diabetes in the non-obese diabetic (NOD) mouse.
口服蛋白质可诱导抗原特异性免疫低反应性。然而,当候选自身抗原无法通过传统系统大量生产以满足临床研究需求时,口服自身抗原耐受性在自身免疫性疾病治疗中的效用可能会受到限制。植物可能非常适合此目的,因为它们可以合成、糖基化并组装哺乳动物蛋白质,以提供大量相对低成本的可溶性蛋白质。此外,可食用转基因植物可为口服耐受性提供一种简单直接的自身抗原递送方法。因此,本研究的目的是确定转基因植物表达系统是否能够以免疫原性形式合成糖尿病相关自身抗原谷氨酸脱羧酶(GAD),以及口服植物表达的自身抗原是否能在糖尿病小鼠模型中直接诱导保护性免疫反应。我们发现,作为膳食补充剂给予的表达GAD的转基因植物可抑制非肥胖糖尿病(NOD)小鼠糖尿病的发展。